Previous 10 | Next 10 |
2023-11-06 10:28:09 ET Summary ANIP's PPS has gained 63.41% YTD and is expected to continue growing. ANIP should record its fifth consecutive quarter beating earnings and revenue consensus. ANIP's Sovuna, a unique version of Hydroxychloroquine sulfate, and a new 1-ml vial vers...
BAUDETTE, Minn., Oct. 30, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will participate at two upcoming healthcare conferences as follows: Trui...
BAUDETTE, Minn., Oct. 25, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2023 financial results on Wednesday, November 8, 2023, prior to the market open. N...
2023-10-18 07:02:30 ET More on ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharma wins FDA nod for generic Estradiol tablets ANI Pharma granted FDA nod for generic Estradiol Gel For further details see: ANI Pharmaceuticals disclo...
2023-10-04 06:55:04 ET More on ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharma wins FDA nod for generic Estradiol tablets ANI Pharma granted FDA nod for generic Estradiol Gel Seeking Alpha’s Quant Rating on ANI Pharmaceutic...
Cortrophin Gel is the only FDA-approved purified corticotropin (ACTH) indicated for the treatment of appropriate patients with acute gouty arthritis flares New 1-mL size furthers ANI’s commitment to providing ACTH options for appropriate acute gouty arthritis flare patients and the...
BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, and Stephen Carey, Chief Financial Officer, will present at the Cantor Global Healthcare Conference 2023 in New York City...
2023-09-12 08:17:06 ET More on ANI Pharma Seeking Alpha’s Quant Rating on ANI Pharmaceuticals Historical earnings data for ANI Pharmaceuticals Financial information for ANI Pharmaceuticals ANI Pharma: Slow And Steady Revenue Generator ANI Pharm...
BAUDETTE, Minn., Sept. 12, 2023 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) for Estradiol Tablets USP. ANI’s Estradi...
2023-09-12 06:36:06 ET Summary ANI Pharmaceuticals is a revenue-generating pharmaceutical manufacturer with a low market cap. The company's rare disease segment, led by its Purified Cortrophin Gel product, is expected to be its primary growth driver. ANI Pharmaceuticals report...
News, Short Squeeze, Breakout and More Instantly...
ANI Pharmaceuticals Inc. Company Name:
ANIP Stock Symbol:
NASDAQ Market:
ANI Pharmaceuticals Inc. Website:
PRINCETON, N.J., July 15, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that following final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA), the Company launched L-Glutamine Oral Po...
2024-07-09 17:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
PRINCETON, N.J., July 02, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that it received U.S. Food and Drug Administration (FDA) approval for the Abbreviated New Drug Application (ANDA) and launched Naproxen Delayed-Release Tablets, USP....